Precision Medicine

For profitWebsite ↗

Also known as: Innovative Precision Medicine Group (IPM), Hangzhou, China. | Precision for Medicine | Precision For Medicine | Precision Oncology | Precision Oncology LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Nov 1, 2016

Last known activity

Jan 23, 2025

Timeline

2010s

Jun 1, 2012
Precision Medicine— Founded
Jan 10, 2018
Quartz Bio— Acquired
Jul 18, 2018
Ethos— Acquired
Oct 16, 2018
ApoCell, Inc.— Acquired
Dec 19, 2018
Stern Investor Relations— Acquired
Mar 6, 2019
SimplicityBio— Acquired

Drugs by trial phase (16 distinct, 12 trials)

Phase 3 (1 own, 0 via acquisition)

Fluciclovine

Phase 2 (6 own, 0 via acquisition)

Phase 1 (6 own, 3 via acquisition)

Indications

Studied for

Subsidiaries (5 direct, 5 total across the full acquisition tree)

Recent trials (11)

NCT06789172CollaboratorPhase 1Jan 23, 2025
NCT05414422CollaboratorPhase 2Feb 1, 2022
NCT04410133CollaboratorPhase 3Sep 30, 2020
NCT04410367CollaboratorPhase 2/Phase 3Jul 31, 2020
NCT04266197CollaboratorPhase 2Mar 31, 2020
NCT04252118CollaboratorPhase 1Feb 1, 2020
NCT04123470CollaboratorPhase 1/Phase 2Jan 1, 2020
NCT04096638CollaboratorPhase 1Sep 30, 2019
NCT03844191CollaboratorPhase 1Feb 18, 2019
NCT03646071Study directorPhase 1Aug 1, 2018
NCT02963493CollaboratorPhase 2Nov 1, 2016

Details

Founded: Bethesda, MD, US Jun 1, 2012
Last known activity: Jan 23, 2025